NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Keefe cuts W.R. Berkley stock price target, maintains Market Perform rating

EditorTanya Mishra
Published 10/22/2024, 09:40 AM
WRB
-

Keefe, Bruyette & Woods has made adjustments to its outlook on W.R. Berkley (NYSE: WRB), a property and casualty insurance company.

The firm reduced the price target on the stock to $58.00, down from the previous $59.00. Despite this change, the analyst maintained a Market Perform rating on the company's shares.

The revision followed W.R. Berkley's latest earnings report, where the company posted an operating EPS of $0.93, slightly above the consensus of $0.92 but below the analyst's expectation of $0.97.

The company's performance against the consensus was attributed to better-than-expected core loss ratios, reserve development, and controlled expenses. However, premium growth, investment income, and catastrophe losses did not meet the expectations set by both the analyst and the consensus.

In response to the recent quarter results and future prospects, the analyst has revised the earnings forecasts for the coming years. The estimated EPS for the years 2024, 2025, and 2026 have been adjusted to $4.10, $4.35, and $4.65 respectively. These figures are a slight decrease from the previous estimates of $4.15, $4.40, and $4.75.

The adjustments reflect the incorporation of the third quarter miss into the forecasts, along with assumptions of lower growth in premium and investment income and higher expense ratios for 2025 and 2026.

In other recent news, W.R. Berkley Corporation reported a record net income of $366 million in Q3 2024, a nearly 10% increase from the previous year. Operating earnings stood at $374 million, or $0.93 per share, surpassing the Visible Alpha Consensus estimate of $0.91.

Despite significant catastrophic events, the company's solid underwriting and investment income have been the primary drivers of this growth. The company's net premiums written (NPW) growth did not meet analyst forecasts, registering around 7% growth compared to the 10% expected.

TD Cowen maintained a positive outlook on W.R. Berkley, reiterating its Buy rating with a steady price target of $68.00. RBC Capital Markets adjusted its price target for the company to $63.00, while Goldman Sachs maintained a Neutral rating with a steady price target of $61.00. Evercore ISI also increased its target price for W.R. Berkley to $60.00, maintaining its "In Line" rating.

Looking ahead, W.R. Berkley projects an annual revenue growth of 10% to 15% and expects sustained growth in underwriting margins and investment income. However, Evercore ISI expressed skepticism about W.R. Berkley achieving its growth target in the fourth quarter of 2024, aligning more with a conservative growth outlook.

InvestingPro Insights

To complement the analysis provided by Keefe, Bruyette & Woods, recent data from InvestingPro offers additional context on W.R. Berkley's financial position and market performance. The company's market capitalization stands at $23.23 billion, with a P/E ratio of 16.01, indicating a relatively moderate valuation compared to earnings.

Notably, W.R. Berkley has demonstrated strong revenue growth, with a 10.26% increase over the last twelve months as of Q2 2024, aligning with the analyst's focus on premium growth. The company's profitability is evident, with a gross profit margin of 43.57% and an operating income margin of 16.36% for the same period.

InvestingPro Tips highlight W.R. Berkley's impressive dividend history, having maintained payments for 50 consecutive years. This consistent dividend performance may provide some reassurance to investors despite the analyst's reduced price target. Additionally, the stock is trading near its 52-week high, with a strong return of 48.09% over the past year, potentially reflecting investor confidence in the company's overall performance.

For investors seeking a more comprehensive analysis, InvestingPro offers 7 additional tips that could provide further insights into W.R. Berkley's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.